Get research updatesAttention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.
Assessing the Effect of Missing Doses (Off-Days) of Daily Medication in Patients Stable on Pharmacotherapy for ADHD Receiving Atomoxetine or OROS Methylphenidate: A Parallel Matched Group Clinical Study (On/Off Study)
This study ended early.
Multiple locations, including ArnhemA Randomized, Multi-center, Double-blind, Cross-over Study Comparing the Efficacy and Safety of Focalin® XR 20 mg Versus Placebo at the 0.5 Hour Timepoint (Post-dose) in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockResearchers compared LY2216684, methylphenidate and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including Spring ValleyResearchers compared JNJ-31001074 1 mg/d, JNJ-31001074 3 mg/d, JNJ-31001074 10 mg/d, Atomoxetine 80 mg/d, OROS methylphenidate HCl 54 mg/d and placebo to find out how the approaches affected ADHD symptoms in adults with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockThis study evaluated the safety of JNJ-31001074 for people with ADHD.
This study has finished and is no longer accepting participants.
Location not clearly listedThis study evaluated the safety of JNJ-31001074 for people with ADHD.
This study has finished and is no longer accepting participants.
Location not clearly listedA Phase Ib, Multicentre, Randomised, Double Blind, Placebo Controlled, 2 Sequence Crossover Trial to Evaluate the Effects of BI 3031185 on Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics in Patients With Borderline Personality Disorder or Attention-deficit/Hyperactivity Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including Berlin
A Systematic Study of ADHD Assessments Within Child and Adolescent Psychiatric Care
This study has finished and is no longer accepting participants.
In UppsalaResearchers studied Centanafadine Hydrochloride, tracking side effects to assess long-term safety and tolerability in children and adolescents with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including Dothan
A Randomized Trial of Computer-based Attention-training Systems With and Without Neurofeedback in Children With ADHD
This study has finished and is no longer accepting participants.
In BostonThis study evaluated the safety of Centanafadine for people with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockThis study evaluated the safety of Centanafadine for people with ADHD.
This study has finished and is no longer accepting participants.
In HollywoodWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.